Fasciola hepatica juveniles interact with the host fibrinolytic system as a potential early-stage invasion mechanism.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
07
11
2022
accepted:
20
03
2023
revised:
03
05
2023
medline:
5
5
2023
pubmed:
21
4
2023
entrez:
21
04
2023
Statut:
epublish
Résumé
The trematode Fasciola hepatica is the most widespread causative agent of fasciolosis, a parasitic disease that mainly affects humans and ruminants worldwide. During F. hepatica infection, newly excysted juveniles (FhNEJ) emerge in the duodenum of the mammalian host and migrate towards their definitive location, the intra-hepatic biliary ducts. Understanding how F. hepatica traverses the intestinal wall and migrates towards the liver is pivotal for the development of more successful strategies against fasciolosis. The central enzyme of the mammalian fibrinolytic system is plasmin, a serine protease whose functions are exploited by a number of parasite species owing to its broad spectrum of substrates, including components of tissue extracellular matrices. The aim of the present work is to understand whether FhNEJ co-opt the functions of their host fibrinolytic system as a mechanism to facilitate trans-intestinal migration. A tegument-enriched antigenic extract of FhNEJ (FhNEJ-Teg) was obtained in vitro, and its capability to bind the zymogen plasminogen (PLG) and enhance its conversion to the active protease, plasmin, were analyzed by a combination of enzyme-linked immunosorbent, chromogenic and immunofluorescence assays. Additionally, PLG-binding proteins in FhNEJ-Teg were identified by bidimensional electrophoresis coupled to mass spectrometry analysis, and the interactions were validated using FhNEJ recombinant proteins. Our results show that FhNEJ-Teg contains proteins that bind PLG and stimulate its activation to plasmin, which could facilitate the traversal of the intestinal wall by FhNEJ and contribute to the successful establishment of the parasite within its mammalian host. Altogether, our findings contribute to a better understanding of host-parasite relationships during early fasciolosis and may be exploited from a pharmacological and/or immunological perspective for the development of treatment and control strategies against this global disease.
Sections du résumé
BACKGROUND
The trematode Fasciola hepatica is the most widespread causative agent of fasciolosis, a parasitic disease that mainly affects humans and ruminants worldwide. During F. hepatica infection, newly excysted juveniles (FhNEJ) emerge in the duodenum of the mammalian host and migrate towards their definitive location, the intra-hepatic biliary ducts. Understanding how F. hepatica traverses the intestinal wall and migrates towards the liver is pivotal for the development of more successful strategies against fasciolosis. The central enzyme of the mammalian fibrinolytic system is plasmin, a serine protease whose functions are exploited by a number of parasite species owing to its broad spectrum of substrates, including components of tissue extracellular matrices. The aim of the present work is to understand whether FhNEJ co-opt the functions of their host fibrinolytic system as a mechanism to facilitate trans-intestinal migration.
METHODOLOGY/PRINCIPAL FINDINGS
A tegument-enriched antigenic extract of FhNEJ (FhNEJ-Teg) was obtained in vitro, and its capability to bind the zymogen plasminogen (PLG) and enhance its conversion to the active protease, plasmin, were analyzed by a combination of enzyme-linked immunosorbent, chromogenic and immunofluorescence assays. Additionally, PLG-binding proteins in FhNEJ-Teg were identified by bidimensional electrophoresis coupled to mass spectrometry analysis, and the interactions were validated using FhNEJ recombinant proteins.
CONCLUSIONS/SIGNIFICANCE
Our results show that FhNEJ-Teg contains proteins that bind PLG and stimulate its activation to plasmin, which could facilitate the traversal of the intestinal wall by FhNEJ and contribute to the successful establishment of the parasite within its mammalian host. Altogether, our findings contribute to a better understanding of host-parasite relationships during early fasciolosis and may be exploited from a pharmacological and/or immunological perspective for the development of treatment and control strategies against this global disease.
Identifiants
pubmed: 37083884
doi: 10.1371/journal.pntd.0010936
pii: PNTD-D-22-01416
pmc: PMC10155961
doi:
Substances chimiques
Fibrinolysin
EC 3.4.21.7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0010936Informations de copyright
Copyright: © 2023 Serrat et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Trop Med Hyg. 2018 Nov;99(5):1180-1185
pubmed: 30226136
Biosci Rep. 2018 Oct 2;38(5):
pubmed: 30166455
Genome Biol. 2015 Apr 03;16:71
pubmed: 25887684
Int J Parasitol. 2020 Aug;50(9):663-669
pubmed: 32531305
PLoS Negl Trop Dis. 2022 Sep 16;16(9):e0010766
pubmed: 36112664
Mol Biochem Parasitol. 2010 Aug;172(2):121-8
pubmed: 20403391
Mol Cell Proteomics. 2009 Aug;8(8):1891-907
pubmed: 19443417
Parasitology. 2019 Mar;146(3):284-298
pubmed: 30246668
Front Cell Infect Microbiol. 2022 Jun 03;12:903602
pubmed: 35719328
Nature. 1997 Jul 10;388(6638):167-71
pubmed: 9217155
PLoS Negl Trop Dis. 2018 Aug 23;12(8):e0005840
pubmed: 30138310
PLoS Negl Trop Dis. 2022 Oct 12;16(10):e0010811
pubmed: 36223411
Acta Trop. 2013 Oct;128(1):116-23
pubmed: 23850506
PLoS Negl Trop Dis. 2016 May 03;10(5):e0004688
pubmed: 27139907
Res Vet Sci. 2021 Jan;134:27-35
pubmed: 33278757
PLoS Negl Trop Dis. 2022 Nov 7;16(11):e0010854
pubmed: 36342907
Curr Vasc Pharmacol. 2006 Apr;4(2):101-16
pubmed: 16611153
Parasite. 2022;29:35
pubmed: 35833785
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14440-5
pubmed: 8962070
Mol Cell Proteomics. 2007 Sep;6(9):1638-55
pubmed: 17533153
J Immunol. 2010 Nov 1;185(9):5628-36
pubmed: 20870944
Mol Biochem Parasitol. 2012 Feb;181(2):134-40
pubmed: 22050927
Int J Environ Res Public Health. 2022 Jan 20;19(3):
pubmed: 35162146
Exp Parasitol. 2007 Jan;115(1):83-91
pubmed: 16962583
Geospat Health. 2014 May;8(2):317-34
pubmed: 24893010
Mol Cell Proteomics. 2018 Apr;17(4):792-809
pubmed: 29321187
Int J Mol Sci. 2022 May 15;23(10):
pubmed: 35628335
Front Cell Infect Microbiol. 2017 Nov 15;7:467
pubmed: 29188194
FEBS Lett. 2004 Apr 9;563(1-3):203-6
pubmed: 15063749
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Adv Parasitol. 2014;84:27-149
pubmed: 24480313
J Thromb Haemost. 2009 Jan;7(1):4-13
pubmed: 19017261
PLoS Negl Trop Dis. 2019 Jan 18;13(1):e0007087
pubmed: 30657764
Cell Mol Life Sci. 2004 Apr;61(7-8):873-85
pubmed: 15095009
Animals (Basel). 2021 Dec 08;11(12):
pubmed: 34944270
Annu Rev Genet. 2020 Nov 23;54:265-285
pubmed: 32870732
Exp Hematol Oncol. 2013 Apr 17;2(1):12
pubmed: 23594883
Trends Immunol. 2004 Aug;25(8):450-5
pubmed: 15275645
Virulence. 2021 Dec;12(1):2839-2867
pubmed: 34696693
Parasit Vectors. 2020 Apr 6;13(1):171
pubmed: 32252808
Ann N Y Acad Sci. 2001;936:226-36
pubmed: 11460480
Trends Parasitol. 2016 Apr;32(4):325-335
pubmed: 26775037
Gut. 1998 Nov;43(5):656-63
pubmed: 9824347
Trends Parasitol. 2021 Jan;37(1):35-47
pubmed: 33067132
Adv Parasitol. 2019;104:113-164
pubmed: 31030768
Br J Haematol. 2005 May;129(3):307-21
pubmed: 15842654
Mol Cell Proteomics. 2015 Dec;14(12):3258-73
pubmed: 26486420
Int J Parasitol. 2008 Feb;38(2):149-55
pubmed: 18048044
Bioorg Khim. 2014 Nov-Dec;40(6):642-57
pubmed: 25895360